123 related articles for article (PubMed ID: 4584170)
1. Long-term cholesterol-lowering effect of colestipol resin in humans.
Gross L; Figueredo R
J Am Geriatr Soc; 1973 Dec; 21(12):552-6. PubMed ID: 4584170
[No Abstract] [Full Text] [Related]
2. Effects of colestipol, a new bile-acid-sequestering resin, on cholesterol metabolism in man.
Miller NE; Clifton-Bligh P; Nestel PJ
J Lab Clin Med; 1973 Dec; 82(6):876-90. PubMed ID: 4758739
[No Abstract] [Full Text] [Related]
3. Long-term treatment of hypercholesterolemia with colestipol hydrochloride.
Ryan JR; Jain AK; McMahon FG
Clin Pharmacol Ther; 1975 Jan; 17(1):83-7. PubMed ID: 1091391
[TBL] [Abstract][Full Text] [Related]
4. Colestipol hydrochloride, a new hypolipidemic drug: a two-year study.
Cooper EE; Michel AM
South Med J; 1975 Mar; 68(3):303-9. PubMed ID: 1091001
[TBL] [Abstract][Full Text] [Related]
5. Controlled clinical trial of a new bile acid-sequestering resin, colestipol, in the treatment of hypercholesterolaemia.
Miller NE; Clifton-Bligh P; Nestel PJ; Whyte HM
Med J Aust; 1973 Jun; 1(25):1223-7. PubMed ID: 4579666
[No Abstract] [Full Text] [Related]
6. The effect of colestipol or cholestyramine on serum cholesterol and triglycerides in a long-term controlled study.
Ryan JR; Jain A
J Clin Pharmacol New Drugs; 1972 Jul; 12(7):268-73. PubMed ID: 4557535
[No Abstract] [Full Text] [Related]
7. Increased plasma cholesterol esterifying activity during Colestipol resin therapy in man.
Clifton-Bligh P; Miller NE; Nestel PJ
Metabolism; 1974 May; 23(5):437-44. PubMed ID: 4825300
[No Abstract] [Full Text] [Related]
8. Treatment of hypercholesterolaemia with colestipol: a bile sequestrating agent.
Nye ER; Jackson D; Hunter JD
N Z Med J; 1972 Jul; 76(482):12-6. PubMed ID: 4344110
[No Abstract] [Full Text] [Related]
9. Colestipol and clofibrate in hypercholesterolemia.
Dujovne CA; Hurwitz A; Kauffman RE; Azarnoff DL
Clin Pharmacol Ther; 1974 Aug; 16(2):291-6. PubMed ID: 4604239
[No Abstract] [Full Text] [Related]
10. Changes in plasma lipoprotein lipids in hypercholesterolaemic patients treated with the bile acid-sequestering resin, colestipol.
Clifton-Bligh P; Miller NE; Nestel PJ
Clin Sci Mol Med; 1974 Dec; 47(6):547-57. PubMed ID: 4375013
[No Abstract] [Full Text] [Related]
11. Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemia.
Glueck CJ; Ford S; Scheel D; Steiner P
JAMA; 1972 Nov; 222(6):676-81. PubMed ID: 4562098
[No Abstract] [Full Text] [Related]
12. Effect of colestipol (U-26,597A) on experimental atherosclerosis in rabbits.
Kritchevsky D; Kim HK; Tepper SA
Proc Soc Exp Biol Med; 1973 Jan; 142(1):185-8. PubMed ID: 4683239
[No Abstract] [Full Text] [Related]
13. The effects of colestipol resin and of colestipol plus clofibrate on the turnover of plasma cholesterol in man.
Goodman DS; Noble RP; Dell RB
J Clin Invest; 1973 Oct; 52(10):2646-55. PubMed ID: 4729058
[TBL] [Abstract][Full Text] [Related]
14. Response of hyperlipoproteinemia to colestipol.
Sachs BA; Wolfman L
N Y State J Med; 1973 May; 73(9):1068-70. PubMed ID: 4512165
[No Abstract] [Full Text] [Related]
15. Colestipol therapy of hyperlipidemia in man.
Sachs BA; Wolfman L
Proc Soc Exp Biol Med; 1974 Dec; 147(3):694-7. PubMed ID: 4445156
[No Abstract] [Full Text] [Related]
16. Effect of colestipol on gastrointestinal absorption of chlorothiazide in man.
Kauffman RE; Azarnoff DL
Clin Pharmacol Ther; 1973; 14(5):886-90. PubMed ID: 4729904
[No Abstract] [Full Text] [Related]
17. Cholesterol-lowering effect of colestipol hydrochloride given twice daily in hypercholesterolemic patients.
Gundersen K; Cooper EE; Ruoff G; Nikolai T; Assenzo JR
Atherosclerosis; 1976; 25(2-3):303-10. PubMed ID: 795441
[TBL] [Abstract][Full Text] [Related]
18. Effect of colestipol, a new bile acid sequestrant, on the absorption of phenprocoumon in man.
Harvengt C; Desager JP
Eur J Clin Pharmacol; 1973 Jun; 6(1):19-21. PubMed ID: 4764368
[No Abstract] [Full Text] [Related]
19. Hypocholesterolemic activity of colestipol in diabetes.
Bandisode MS; Boshell BR
Curr Ther Res Clin Exp; 1975 Aug; 18(2):276-84. PubMed ID: 809240
[No Abstract] [Full Text] [Related]
20. Colestipol in familial type II hyperlipoproteinemia: a three-year trial.
Harvengt C; Desager JP
Clin Pharmacol Ther; 1976 Sep; 20(3):310-4. PubMed ID: 182429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]